Intrexon | XON - SCHULD





SCHULD Veränderung Datum
Agenus USD 35.54M 2.34M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 57.3B 19M 2026-06
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 983.69M 5.77M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Heron Therapeutics USD 149.65M 157K 2024-09
Incyte USD 38.27M 1.16M 2026-06
Intrexon USD 0 13.82M 2024-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 1.13B 679.48M 2026-06
MacroGenics USD 35.09M 1.42M 2026-06
MannKind USD 330.85M 112K 2026-06
Merck USD 53.91B 4.79B 2026-06
Novartis USD 49.01B 2.02B 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Thermo Fisher Scientific USD 42.55B 612M 2026-06
Veracyte USD 40.11M 774K 2026-06
Xencor USD 170.11M 5.06M 2026-06